Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > BREAKING: First Charges in Generic Price Fixing Probe Filed
View:
Post by GenericAdvocate on Dec 14, 2016 12:01pm

BREAKING: First Charges in Generic Price Fixing Probe Filed

Developiong news story on now
 

All generic price gougers will get what has been coming to them

VRX CXRX

Comment by JJBronx on Dec 14, 2016 12:05pm
No mention of Concordia or VRX... fake news posts on Bullboards should be illegal. https://www.bloomberg.com/news/articles/2016-12-14/u-s-files-first-charges-in-generic-drug-price-fixing-probe
Comment by GenericAdvocate on Dec 14, 2016 12:19pm
The Covis drugs are the ones purchased by Concordia in 2015.  Covis is mentioned because the investigation started on these drugs in 2015, right before Cncordia bought them.   Not fake news pumper.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities